Please find enclosed herewith the Scutinizer Report, along with Voting Results under Regulations 44
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parnax Lab Limited held its 43rd Annual General Meeting on 29th September 2025 via video conferencing. Four ordinary resolutions were put to vote, and all were passed with 100% votes in favour and zero votes against. The resolutions covered: (1) adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, (2) re-appointment of Mr. Binoy B. Shah (DIN: 00440880) as a director retiring by rotation, (3) approval of material related party transactions with Naxpar Pharma Private Limited, and (4) appointment of secretarial auditors. Total of 83,61,341 votes were cast in favour of resolutions 1, 2, and 4, while 4,22,319 votes were cast in favour of the related party transaction resolution, as the promoter and promoter group (holding 83,03,766 shares) abstained from voting on that item due to their interest. The e-voting process was conducted via MUFG Intime India Pvt. Ltd. and scrutinized by HSPN & Associates LLP.
All four resolutions passed unanimously with full shareholder support, indicating no governance friction at the AGM. The related party transaction with Naxpar Pharma was approved solely by public non-institutional shareholders, with promoters recusing themselves, which is standard procedure. This is a routine compliance filing with no material negative signals for shareholders.